Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs have been in high demand globally due to the COVID-19 pandemic. Laos, a small country in Southeast Asia, has also seen a surge in the demand for antiviral drugs.
Customer preferences: In Laos, the majority of the population lives in rural areas with limited access to healthcare facilities. As a result, they tend to rely on traditional medicine and home remedies. However, with the COVID-19 pandemic, there has been a shift in customer preferences towards modern medicine, including antiviral drugs. The urban population, in particular, has been more inclined towards using antiviral drugs to prevent and treat COVID-19.
Trends in the market: The demand for antiviral drugs in Laos has increased significantly due to the COVID-19 pandemic. The government has been taking measures to ensure an adequate supply of antiviral drugs in the country. However, the market for antiviral drugs in Laos is still in its nascent stage, and there is a significant potential for growth. The demand for antiviral drugs is expected to continue to rise in the coming years due to the increasing awareness about the benefits of modern medicine.
Local special circumstances: Laos is a landlocked country with a small population and limited resources. The healthcare infrastructure in the country is underdeveloped, and there is a shortage of healthcare professionals. The government has been working on improving the healthcare system, but there is still a long way to go. In addition, the country is heavily dependent on imports for pharmaceuticals, including antiviral drugs. This makes the country vulnerable to supply chain disruptions and price fluctuations.
Underlying macroeconomic factors: Laos is one of the fastest-growing economies in Southeast Asia. The country has been transitioning from a subsistence-based economy to a market-based economy, which has led to an increase in the disposable income of the population. This, in turn, has led to an increase in the demand for healthcare services, including antiviral drugs. The government has been investing in healthcare infrastructure and has set a target of achieving universal healthcare coverage by 2025. These factors are expected to drive the growth of the antiviral drugs market in Laos in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
